• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (3)
    • Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
    • Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    • o-Phthalaldehyde
    • See All 3 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst. 2015 Sep; 107(9).

View in: PubMed

subject areas
  • Adaptor Proteins, Signal Transducing
  • Adenosine Triphosphatases
  • Adult
  • Aged
  • Anticarcinogenic Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
  • Bias
  • Colorectal Neoplasms
  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • DNA Mismatch Repair
  • DNA Repair Enzymes
  • DNA-Binding Proteins
  • Female
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Ibuprofen
  • Male
  • Middle Aged
  • Mismatch Repair Endonuclease PMS2
  • MutL Protein Homolog 1
  • MutS Homolog 2 Protein
  • Nuclear Proteins
  • Prevalence
  • Proportional Hazards Models
  • Registries
  • United States

authors with profiles
  • Robert W. Haile